Denovo Biopharma has acquired 1 company, including 1 in the last 5 years.
Denovo Biopharma has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
10240 Science Center Drive, Suite120,
San Diego, California
92121
United States,
www.denovobiopharma.com
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2020-04-28 |
Tocagen, Inc. - Replicating Gene Therapy Platform and Related Assets · Life Science
, California Tocagen, Inc. - Replicating Gene Therapy Platform and Related Assets includes investigational gene therapy and drug regimen for oncology: Toca 511 and Toca FC (now known as DB107), and several early-stage development programs, including programs targeting PD-L1 and other Immuno-oncology targets. |
- | Divestiture |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
